Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian M Thompson

Showing results (51-60 of 484) with videos related to

Pageof 49
Sort By:
BJU International|June 28, 2007
Controversies regarding screening for prostate cancerE David Crawford, Ian M Thompson
The Journal of Urology|April 8, 2006
Diagnosing prostate cancer: through a glass, darklyIan M Thompson, M Scott Lucia
European Urology|May 30, 2012
Words of wisdom. Re: Combining 33 genetic variants with prostate-specific antigen for the prediction of prostate cancer: longitudinal studyDonna P Ankerst, Ian M Thompson
Current Opinion in Urology|November 3, 2017
Prostate cancer prevention with 5-alpha reductase inhibitors: concepts and controversiesMichael A Liss, Ian M Thompson
Urology|November 14, 2002
Impact of diabetes mellitus on the presentation and outcomes of Fournier's gangreneAlan A Nisbet, Ian M Thompson
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 3, 2007
Merging digital rectal exam, family history, age and prostate-specific antigen to create a decision-making toolDonna Pauler Ankerst, Ian M Thompson
BMJ (Clinical Research Ed.)|November 25, 2006
Clinically localised prostate cancerTimothy J Wilt, Ian M Thompson
European Urology|February 11, 2016
The Role of Magnetic Resonance Imaging in Prostate Cancer: Focusing on What Really MattersIan M Thompson, Donna P Ankerst
World Journal of Urology|May 21, 2003
The Prostate Cancer Prevention Trial: design, status, and promiseIan M Thompson, Catherine Tangen, Phyllis Goodman
Nature Clinical Practice. Oncology|November 3, 2005
Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practiceEdith D Canby-Hagino, Ian M Thompson
Pageof 49

Showing results (51-60 of 484) with videos related to

Sort By:
Pageof 49
BJU International|June 28, 2007
Controversies regarding screening for prostate cancerE David Crawford, Ian M Thompson
The Journal of Urology|April 8, 2006
Diagnosing prostate cancer: through a glass, darklyIan M Thompson, M Scott Lucia
European Urology|May 30, 2012
Words of wisdom. Re: Combining 33 genetic variants with prostate-specific antigen for the prediction of prostate cancer: longitudinal studyDonna P Ankerst, Ian M Thompson
Current Opinion in Urology|November 3, 2017
Prostate cancer prevention with 5-alpha reductase inhibitors: concepts and controversiesMichael A Liss, Ian M Thompson
Urology|November 14, 2002
Impact of diabetes mellitus on the presentation and outcomes of Fournier's gangreneAlan A Nisbet, Ian M Thompson
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|February 3, 2007
Merging digital rectal exam, family history, age and prostate-specific antigen to create a decision-making toolDonna Pauler Ankerst, Ian M Thompson
BMJ (Clinical Research Ed.)|November 25, 2006
Clinically localised prostate cancerTimothy J Wilt, Ian M Thompson
European Urology|February 11, 2016
The Role of Magnetic Resonance Imaging in Prostate Cancer: Focusing on What Really MattersIan M Thompson, Donna P Ankerst
World Journal of Urology|May 21, 2003
The Prostate Cancer Prevention Trial: design, status, and promiseIan M Thompson, Catherine Tangen, Phyllis Goodman
Nature Clinical Practice. Oncology|November 3, 2005
Mechanisms of disease: Prostate cancer--a model for cancer chemoprevention in clinical practiceEdith D Canby-Hagino, Ian M Thompson
Pageof 49